<DOC>
	<DOCNO>NCT02481804</DOCNO>
	<brief_summary>This study aim investigate optimal personalize consultation dietician healthy diet focus food contains sufficient vitamin mineral improve gastrointestinal symptom determine improved score gastrointestinal symptom NET specific EORTC QLQ-GINET21 end study .</brief_summary>
	<brief_title>Optimal Feeding NET Patients</brief_title>
	<detailed_description>Rationale : Patients neuroendocrine tumor ( NET ) rare , slowly progress disease . Therefore undergo many treatment surgery follow long-lasting systemic treatment somatostatin analogue . These procedure result increase diarrhea loss critical food component stool fat . This lead amongst others , major loss fat-soluble vitamin . Those patient addition ongoing serotonin production may experience shortage circulate essential amino acid tryptophan . Serotonin derive essential amino acid tryptophan . Tryptophan precursor niacin ( vitamin B3 ) critical normal cellular metabolism . In case high serotonin production neuroendocrine tumor patient tryptophan and/or niacin deficient lead symptom include pellagra . Suppletion tryptophan might facilitate serotonin production therefore , undesirable patient serotonin produce neuroendocrine tumor . Strikingly little known NET patient best support deficit develop long-lasting disease . Also precise effect diet advice diarrhea fat-soluble vitamin vitamin B3 , patient group unknown . Patients NET face serious chronic disease . This make patient group extremely motivate involved treatment `` self-manage '' disease much possible . Objective : This study aim investigate optimal personalize consultation dietician healthy diet focus food contains sufficient vitamin mineral improve gastrointestinal symptom determine improved score gastrointestinal symptom NET specific EORTC QLQ-GINET21 end study . Secondary aim decrease distress distress thermometer , improvement quality life determine cancer-specific EORTC QLQ-C30 , construct EORTC QLQ-GINET21 , empowerment ( subscales Construct Empowering Outcomes questionnaire ) end study , improvement nutrition state ( Patient-Generated Subjective Global Assessment PG/SGA ) normalization vitamin tryptophan level end study measure quantitative analysis blood urine . Study design : This single center 18 week open-label , non-comparative , single-arm , experimental pilot study . In pilot want examine effect size gastrointestinal symptom NET specific EORTC QLQ-GINET21 patient dietary intervention . Four week inclusion adult patient metastasized NET chronic use ( &gt; 6 month ) somatostatin analogue start dietary intervention . Effects intervention evaluate questionnaire vitamin value blood urine . Patients fill questionnaire baseline , four week , 18 week . Furthermore baseline , four week , 18 week vitamin value blood urine measure baseline . Study population : Patients treat University Medical Center Groningen metastasize NET treat somatostatin analogue 6 month eligible .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<criteria>Adult NET patient ( age ≥ 18 year age ) , serotonine produce nonserotonin produce tumor , tumor site disease stage . Use somatostatin analogue &gt; 6 month . Ability comprehend Dutch ( read write ) . Written inform consent provide . Estimated life expectancy le 3 month . Patients history another primary malignancy , except radical adequately treated malignancy patient disease free ≥ 3 year . Major abdominal surgery study period . Known hypersensitivity ( component ) somatostatin analogue .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>diet</keyword>
	<keyword>vitamin</keyword>
</DOC>